Deepika Saraswat Selected Research

PQQ Cofactor (Pyrroloquinoline Quinone)

4/2022	Nanocurcumin formulation: a possible therapeutic agent for post COVID inflammatory syndrome.
1/2022	A Nanocurcumin and Pyrroloquinoline Quinone Formulation Prevents Hypobaric Hypoxia-Induced Skeletal Muscle Atrophy by Modulating NF-κB Signaling Pathway.
12/2017	Nanocurcumin-pyrroloquinoline formulation prevents hypertrophy-induced pathological damage by relieving mitochondrial stress in cardiomyocytes under hypoxic conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deepika Saraswat Research Topics

Disease

14	Hypoxia (Hypoxemia) 04/2022 - 01/2014
3	Hypertrophy 12/2017 - 01/2015
2	Edema (Dropsy) 04/2022 - 12/2016
2	Lung Injury 04/2022 - 12/2016
2	Right Ventricular Hypertrophy 04/2022 - 12/2017
2	Neoplasms (Cancer) 01/2022 - 01/2014
1	COVID-19 04/2022
1	Atrophy 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Inflammation (Inflammations) 10/2018
1	Pulmonary Edema 10/2018
1	Acute Lung Injury 12/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Salmonella Infections (Salmonellosis) 11/2013

Drug/Important Bio-Agent (IBA)

8	Oxygen (Dioxygen)IBA 01/2022 - 01/2014
3	PQQ Cofactor (Pyrroloquinoline Quinone)IBA 04/2022 - 12/2017
3	CurcuminIBA 12/2016 - 06/2015
2	CytokinesIBA 04/2022 - 12/2016
2	Therapeutic UsesIBA 04/2022 - 12/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 05/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018 - 01/2017
2	Caspase 3 (Caspase-3)IBA 06/2015 - 10/2014
2	Atrial Natriuretic Factor (ANF)IBA 06/2015 - 01/2015
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 02/2014 - 01/2014
1	AntioxidantsIBA 04/2022
1	C-Reactive ProteinIBA 04/2022
1	CalpainIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	CTLA-4 AntigenIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	caffeic acid phenethyl esterIBA 10/2018
1	pyrazolanthroneIBA 10/2018
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	Indicators and Reagents (Reagents)IBA 10/2018
1	InterferonsIBA 10/2018
1	Interleukin-1 (Interleukin 1)IBA 10/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018
1	pyrroloquinolineIBA 12/2017
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 01/2017
1	Adenosine Triphosphatases (ATPase)IBA 12/2016
1	Endothelin Receptors (Endothelin Receptor)IBA 12/2016
1	Sunitinib (Sutent)FDA Link 05/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2015
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2015
1	TransferasesIBA 01/2015
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2015
1	Histones (Histone)IBA 01/2015
1	P-300IBA 01/2015
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2014
1	CalciumIBA 10/2014
1	Adenosine Triphosphate (ATP)IBA 10/2014
1	Amlodipine (Norvasc)FDA LinkGeneric 10/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2014
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2014
1	Pharmaceutical PreparationsIBA 01/2014
1	Biological ProductsIBA 01/2014
1	Interleukin-22 (IL-22)IBA 11/2013

Therapy/Procedure

1	Therapeutics 09/2017